Eden Research (LON:EDEN) Shares Down 8.3% – Time to Sell?

Eden Research plc (LON:EDEN) dropped 8.3% during trading on Friday . The stock traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.30 ($0.04). Approximately 280,171 shares changed hands during mid-day trading, a decline of 70% from the average daily volume of 928,276 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Trading Down 3.3 %

The stock has a market cap of £18.56 million, a price-to-earnings ratio of -12.19 and a beta of 0.92. The business has a 50-day simple moving average of GBX 3.87 and a two-hundred day simple moving average of GBX 3.95. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.42 and a current ratio of 3.80.

Insider Buying and Selling

In related news, insider Lykele van der Broek bought 256,000 shares of the stock in a transaction that occurred on Thursday, February 6th. The shares were acquired at an average price of GBX 4 ($0.05) per share, with a total value of £10,240 ($12,937.46). Also, insider Alexander John Abrey bought 540,540 shares of the company’s stock in a transaction that occurred on Tuesday, January 28th. The shares were bought at an average price of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,317.25). 14.02% of the stock is currently owned by corporate insiders.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.